Cargando…

Editorial: Ferroptosis as a novel therapeutic target for inflammation-related diseases

Detalles Bibliográficos
Autores principales:	Liang, Yongyi, Su, Zhenyi, Mao, Xiaoyuan, Wan, Shibiao, Luo, Lianxiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978696/ https://www.ncbi.nlm.nih.gov/pubmed/36874022 http://dx.doi.org/10.3389/fphar.2023.1152326

Ejemplares similares

Editorial: Liver diseases and programmed cell death
por: Cao, Peng, et al.
Publicado: (2023)

Ferroptosis as a therapeutic target for inflammation-related intestinal diseases
por: Zhang, Xiaoli, et al.
Publicado: (2023)

Editorial: Emerging strategies for cancer therapy targeting ferroptosis
por: Li, Manshan, et al.
Publicado: (2023)

Targeting ferroptosis as novel therapeutic approaches for epilepsy
por: Jin, Yuzi, et al.
Publicado: (2023)

Editorial: Ferroptosis as new therapeutic targets in cancer: From molecular mechanisms to therapeutic opportunities
por: Chen, Jian, et al.
Publicado: (2022)

Editorial: Cancer of gastrointestinal tract: Novel insight into the molecular mechanisms related to inflammation and therapeutic targets
por: Banerjee, Aditi, et al.
Publicado: (2022)

Ferroptosis as an emerging therapeutic target in liver diseases
por: Lu, Yuzhen, et al.
Publicado: (2023)

Induction mechanism of ferroptosis: A novel therapeutic target in lung disease
por: Pan, Lingyu, et al.
Publicado: (2022)

Molecular mechanisms of ferroptosis and the potential therapeutic targets of ferroptosis signaling pathways for glioblastoma
por: Zhang, Meng, et al.
Publicado: (2022)

Editorial: Implications of Ferroptosis-Related Genes to the Genetics of Cancer Development
por: Li, Manshan, et al.
Publicado: (2022)

Editorial: New Therapeutic Approaches Against Inflammation and Immune Regulation in Metabolic Related Diseases
por: Lu, Yao, et al.
Publicado: (2022)

Ferroptosis: A new therapeutic target for bladder cancer
por: Zeng, Fan, et al.
Publicado: (2022)

Editorial: Novel Therapeutic Targets and Emerging Treatments for Fibrosis
por: Samuel, Chrishan S., et al.
Publicado: (2017)

Editorial: IBD Management—Novel Targets and Therapeutic Perspectives
por: Antonioli, Luca, et al.
Publicado: (2020)

Targeting ferroptosis as a promising therapeutic strategy to treat cardiomyopathy
por: Sun, Huiyan, et al.
Publicado: (2023)

Compounds targeting ferroptosis in breast cancer: progress and their therapeutic potential
por: Xu, Chuchu, et al.
Publicado: (2023)

Pharmacological modulation of ferroptosis as a therapeutic target for liver fibrosis
por: Li, Le, et al.
Publicado: (2023)

Editorial: Novel therapeutic target and drug discovery for neurological diseases
por: Zhao, Kaiyue, et al.
Publicado: (2022)

Editorial: Novel therapeutic approaches to target drug resistant tumors
por: Riganti, Chiara, et al.
Publicado: (2023)

The lysosome as a novel therapeutic target of EGFR-mediated tumor inflammation
por: Sung, Woo Jung, et al.
Publicado: (2022)

New insights in ferroptosis: Potential therapeutic targets for the treatment of ischemic stroke
por: Wei, Ziqing, et al.
Publicado: (2022)

Iron dyshomeostasis and ferroptosis in Alzheimer’s disease: Molecular mechanisms of cell death and novel therapeutic drugs and targets for AD
por: Zhang, Yuan, et al.
Publicado: (2022)

Editorial: Targeting the Chemoattractant System in Inflammation
por: Hosoya, Tadashi, et al.
Publicado: (2021)

Editorial: Novel Therapeutic Target and Drug Development in Neurovascular Retinal Diseases
por: Shao, Zhuo, et al.
Publicado: (2021)

Editorial: Recent advances in novel therapeutic molecules and targets for inflammatory diseases
por: Li, Feng, et al.
Publicado: (2023)

Molecular mechanisms of ferroptosis and relevance to inflammation
por: Deng, Liyan, et al.
Publicado: (2022)

Editorial: Autophagy in Inflammation Related Diseases
por: Shao, Bo-Zong, et al.
Publicado: (2022)

Targeting ferroptosis, a novel programmed cell death, for the potential of alcohol-related liver disease therapy
por: Shi, Jing-Fen, et al.
Publicado: (2023)

Editorial: Therapeutic Index for Nutraceuticals in Inflammation-Related Diseases: Efficacy, Bioavailability, Metabolism and Interactions With Drugs
por: Peluso, Ilaria, et al.
Publicado: (2020)

Editorial: Pharmacological Approaches Targeting Neutrophilic Inflammation
por: Chernyak, Boris V., et al.
Publicado: (2021)

Editorial: Targeting inflammation to prevent complications in stroke
por: Varela, Lourdes M., et al.
Publicado: (2023)

Role of ferroptosis and ferroptosis-related non-coding RNAs in the occurrence and development of gastric cancer
por: Lu, Ling, et al.
Publicado: (2022)

Editorial: Epigenetic mechanisms and post-translational modifications as novel therapeutic targets in cancer
por: Shi, Zhi, et al.
Publicado: (2022)

Editorial: New compounds, novel targets and mechanism study in inflammation-associated liver diseases
por: Wu, Baoming
Publicado: (2022)

Editorial: Inflammation in Cardiovascular Diseases: Role of the Endothelium and Emerging Therapeutics
por: Qin, Cheng Xue, et al.
Publicado: (2020)

Ferroptosis as a promising therapeutic strategy for melanoma
por: Ta, Na, et al.
Publicado: (2023)

Editorial: Innovative Biologics and Drugs to Target Renal Inflammation
por: Griffin, Matthew D., et al.
Publicado: (2020)

Editorial: Targeting Monocytes/Macrophages to Treat Atherosclerotic Inflammation
por: Corti, Alessandro, et al.
Publicado: (2020)

Editorial: Therapeutic targeting of splicing variants in cancer
por: Sarvari, Pouya, et al.
Publicado: (2023)

Construction of a ferroptosis scoring system and identification of LINC01572 as a novel ferroptosis suppressor in lung adenocarcinoma
por: Hong, Lingling, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_snkpd73l1iqtf1gmjcj9ohhbjj